Allogene Therapeutics

NASDAQ
ALLO
Stock
Yield per half year: -13.58%
Dividend yield: 0%
Sector: Healthcare
News
CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years

10 july 17:59 CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years